-
Company Insights
New![]()
Innovation and Patenting activity of Fast Retailing Co Ltd Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Fast Retailing Co Ltd Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Track & Monitor
New![]()
Electric vehicles in power: DC fast charging EVs
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the power industry’s DC fast charging EVs within Electric Vehicles innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with...
-
Analyst Opinions
New![]()
Experience Economy – Consumer TrendSights Analysis, 2023
Trendsights Analysis on Experience Economy focuses on how consumers are becoming less materialistic and start looking for more immersive experiences. The trend is part of the Sensory & Indulgence mega-trend, and explores the growing demand for unusual, sensory-oriented shopping and consumption experiences. As the shopping experience for the fast-moving consumer goods is becoming increasingly standardized, a rising number of consumers are looking for something more than just the physical product itself. Individuals are becoming more ‘experience-driven’, therefore brands need to...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Mebufotenin in Treatment Resistant Depression
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Mebufotenin in Treatment Resistant Depression Drug Details: BPL-003 is under development for the treatment of treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – INE-963 in Malaria
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.INE-963 in MalariaDrug Details: INE-963 is under development for the treatment of uncomplicated plasmodium falciparum malaria....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – HBI-3000 in Atrial Fibrillation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. HBI-3000 in Atrial Fibrillation Drug Details: HBI-3000 (sulcardine sulfate) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – O-Methylbufotenine in Treatment Resistant Depression
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.O-Methylbufotenine in Treatment Resistant Depression Drug Details:5-MeO-DMT (O-Methylbufotenine) is under development for the treatment of treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NXT-007 in Hemophilia A (Factor VIII Deficiency)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.NXT-007 in Hemophilia A (Factor VIII Deficiency) Drug Details:NXT-007 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Insulin Glargine + Insulin Lispro) La in Type 2 Diabetes
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Insulin Glargine + Insulin Lispro) La in Type 2 Diabetes Drug Details: BioChaperone combo, is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Insulin Lispro U100 in Type 1 Diabetes (Juvenile Diabetes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Insulin Lispro U100 in Type 1 Diabetes (Juvenile Diabetes) Drug Details:Insulin lispro is under development for...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.